Veracyte Names Sangeeta Bhorade, M.D., Medical Director of Pulmonology

This Week’s News in Review

This Week's News in Review! Medical Device News Magazine keeps our readers up-to-date on breaking industry news! Learn how Medical Device News Magazine can help...

New Research Shows Nearly Half of Elderly Suffer Decreased Mobility During Lockdown

In a survey of UK adults with parents over the age of 75, while over half (52%) of respondents remain worried about their parents catching Covid, 48 percent are concerned about parental loneliness, and 46 percent about their parents falling alone and not being able to get up or get help. This figure remained high even among those whose parents are in care homes, with 37% of respondents still most concerned about parents falling over.

American College of Cardiology Names Ravee Kurian COO/CFO

Kurian comes to ACC following a 20-year stint at Publicis Sapient, a leading technology and communications consultancy, where he led critical and sensitive digital transformation initiatives for Fortune 500 and U.S. federal clients.

 

Photograph of Sangeeta Bhorade, M.D.
Sangeeta Bhorade, M.D.

Veracyte, Inc. (Nasdaq: VCYT), a leading genomic diagnostics company, today announced that it has named Sangeeta Bhorade, M.D., medical director of pulmonology. In this role, Dr. Bhorade will lead medical affairs for Veracyte’s pulmonology products, including the Percepta® Bronchial Classifier and Envisia™ Genomic Classifier. Dr. Bhorade will report to Giulia Kennedy, Ph.D., Veracyte’s chief scientific and medical officer.

Prior to joining Veracyte, Dr. Bhorade was professor of medicine and the medical director of the Lung Transplant Program in the Pulmonary and Critical Care Division at Northwestern University Feinberg School of Medicine. During her tenure at Northwestern University, Dr. Bhorade launched its Lung Transplant Program and provided research and clinical expertise as a principal faculty member of the Interstitial Lung Disease Program. She also initiated the Lung Transplant Program at the University of Chicago and served as its medical director.

“We are thrilled to welcome Sangeeta to the Veracyte team,” said Bonnie Anderson, Veracyte’s chairman and chief executive officer. “As a leader in the field of pulmonology, she brings a wealth of expertise and experience to our pulmonary program and will be instrumental in helping us advance early detection, improve diagnosis and inform treatment decisions for patients.”

“I am excited to join Veracyte and provide clinical and research expertise to help shape the company’s portfolio of pulmonary diagnostics,” said Dr. Bhorade. “I look forward to helping patients get access to these scientifically advanced tests that may help improve their health outcomes and cost of care.”

Dr. Bhorade is board certified in pulmonary and critical care medicine. She received her B.A. from the University of Chicago and her medical degree from the University of Chicago Pritzker School of Medicine. Dr. Bhorade has been voted a “Top Doctor” in pulmonology by U.S. News and World Report for the past seven years.

spot_img

DON'T MISS

Dr Jonathan Slotkin Appointed to Peer Well Board of Directors

Alongside the appointment, PeerWell is launching its new clinical practice, PeerWell Health.

Zimmer Biomet Announces New Appointments to Executive Leadership Team

Wilfred van Zuilen Appointed as President of Europe, Middle East and Africa. Nitin Goyal, M.D. Appointed to Newly Created Role of Chief Science, Technology and Innovation Officer.

Subscribe to Medical Device News Magazine here.

Related Articles

Join our list

Subscribe to our mailing list and receive an end-of-week recap news and updates delivered right to your email inbox.